KAL1 Antikörper
-
- Target Alle KAL1 Antikörper anzeigen
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KAL1 Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (IF)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- A synthetic peptide of human KAL1 (NP_000207.2).
- Isotyp
- IgG
- Top Product
- Discover our top product KAL1 Primärantikörper
-
-
- Applikationshinweise
- IF 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- KAL1 (Kallmann Syndrome 1 Sequence (KAL1))
- Andere Bezeichnung
- KAL1 (KAL1 Produkte)
- Hintergrund
- Mutations in this gene cause the X-linked Kallmann syndrome. The encoded protein is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity.
- Gen-ID
- 3730
- UniProt
- P23352
-